Transmission of influenza virus in a mammalian host is increased by PB2 amino acids 627K or 627E/701N.

PLoS Pathogens
John SteelPeter Palese

Abstract

Since 2003, more than 380 cases of H5N1 influenza virus infection of humans have been reported. Although the resultant disease in these cases was often severe or fatal, transmission of avian influenza viruses between humans is rare. The precise nature of the barrier blocking human-to-human spread is unknown. It is clear, however, that efficient human-to-human transmission of an antigenically novel influenza virus would result in a pandemic. Influenza viruses with changes at amino acids 627 or 701 of the PB2 protein have been isolated from human cases of highly pathogenic H5 and H7 avian influenza. Herein, we have used the guinea pig model to test the contributions of PB2 627 and 701 to mammalian transmission. To this end, viruses carrying mutations at these positions were generated in the A/Panama/2007/99 (H3N2) and A/Viet Nam/1203/04 (H5N1) backgrounds. In the context of either rPan99 or rVN1203, mutation of lysine 627 to the avian consensus residue glutamic acid was found to decrease transmission. Introduction of an asparagine at position 701, in conjunction with the K627E mutation, resulted in a phenotype more similar to that of the parental strains, suggesting that this residue can compensate for the lack of 627K in terms o...Continue Reading

References

Oct 9, 1999·Journal of Virology·E FodorA García-Sastre
Jan 28, 2004·Proceedings of the National Academy of Sciences of the United States of America·Ron A M FouchierAlbert D M E Osterhaus
Jan 22, 2005·The Journal of General Virology·Pilaipan PuthavathanaPathom Sawanpanyalert
Jul 15, 2005·Journal of Virology·Kyoko ShinyaYoshihiro Kawaoka
Dec 13, 2005·Proceedings of the National Academy of Sciences of the United States of America·G GabrielJ Stech
Jun 21, 2006·Proceedings of the National Academy of Sciences of the United States of America·Anice C LowenPeter Palese
Aug 2, 2006·Proceedings of the National Academy of Sciences of the United States of America·Taronna R MainesJacqueline M Katz
Nov 14, 2006·The Journal of General Virology·Masaji MaseShigeo Yamaguchi
Apr 27, 2007·Journal of Virology·Hui-Ling YenRobert G Webster
Jun 8, 2007·Emerging Infectious Diseases·Mongkol UiprasertkulPrasert Auewarakul
Jun 16, 2007·The Journal of Infectious Diseases·Vincent J MunsterRon A M Fouchier
Aug 10, 2007·Journal of Virology·Bernadette Crescenzo-Chaigne, Sylvie van der Werf
Oct 10, 2007·PLoS Pathogens·Masato HattaYoshihiro Kawaoka
Oct 24, 2007·PLoS Pathogens·Anice C LowenPeter Palese
May 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·Jessica A BelserTerrence M Tumpey
Jul 19, 2013·Journal of Virology·Ji-Young MinKanta Subbarao

❮ Previous
Next ❯

Citations

May 23, 2014·PLoS Medicine·Marc Lipsitch, Alison P Galvani
Oct 1, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·E J A SchrauwenR A M Fouchier
Feb 1, 2014·Emerging Microbes & Infections·Eefje Ja Schrauwen, Ron Am Fouchier
Jan 15, 2014·Acta Crystallographica. Section F, Structural Biology Communications·Toshiharu TsurumuraHideaki Tsuge
Jan 11, 2014·The Journal of Infection·Kelvin K W ToKwok-Yung Yuen
Sep 13, 2014·Future Virology·Mathilde RichardSander Herfst
Oct 1, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Pi-Han LinPan-Chyr Yang
Apr 9, 2014·Journal of Immunological Methods·Rajagowthamee R Thangavel, Nicole M Bouvier
Dec 19, 2014·BMC Medical Genomics·Christine L P EngTin Wee Tan
Mar 7, 2009·Journal of Virology·Quynh Mai LeYoshihiro Kawaoka
Apr 22, 2009·Proceedings of the National Academy of Sciences of the United States of America·Erin M SorrellDaniel R Perez
Jun 13, 2009·Journal of Biology·Peter C Doherty, Stephen J Turner
Sep 24, 2009·Journal of the Royal Society, Interface·Raymond Tellier
Nov 17, 2009·PLoS Computational Biology·Asif U TamuriRichard A Goldstein
Dec 17, 2009·Emerging Infectious Diseases·Guang-Wu Chen, Shin-Ru Shih
Nov 27, 2010·Molecular Biology and Evolution·Mario dos ReisRichard A Goldstein
Apr 20, 2011·Virology Journal·Rajagowthamee R ThangavelStephen J Stray
Aug 10, 2011·Proceedings of the National Academy of Sciences of the United States of America·Hui-Ling YenMalik Peiris

❮ Previous
Next ❯

Datasets Mentioned

BETA
DQ487334
AY651719

Methods Mentioned

BETA
transfection
PCR
lavage
transfect

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.